Clinical trial

Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer

NCT00345293

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-06-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2006-06-01Date precision: month

Registry last updated2016-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

autologous dendritic cell vaccine (DC/PC3)BIOLOGICAL

Sponsors & collaborators

Rockefeller Universitylead sponsor

Memorial Sloan Kettering Cancer Centercollaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00345293 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.